DOULA & LIMBE
CINPHARM
SARL, DOUALA
Cinpharm is owned by a consortium and started drug production in 2011. The company produces antibiotics, antifungal, pain killers, and IV fluids following international standards of production called cGMP, which stands for “current Good Manufacturing Practice”.
Currently, Cinpharm is reorganizing and looking for strategic alliances and partners. The company wants to branch into more lucrative specialty drug markets such as oncology and high blood pressure drugs, which are scarcely available in Cameroon.
To my left: Prof. Simon Efange from the University of Buea, and Dr. Issa Hamajodad, former Cinpharm production pharmacist, now with Stride, Cameroon.
TRADEMARK: “MADE IN CAMEROON”
Cinpharm has been producing generic drugs since 2011. Currently, the company halted all production and is negotiating the partnership with an international drug manufacturer. At the same time Strides, India in collaboration with a Cameroon Pharmacist is building an even larger company with more manufacturing capacity, also in Douala.
LEARN MORE
About Drug production and training needs in Cameroon by reading the White Paper.
DRUG PRODUCTION AND COLLABORATIONS
AIDSfreeAFRICA mission is to support people in Africa to built their own pharmaceutical production capability.
DIAMOND PHARMACEUTICALS
Diamond Pharmaceuticals was the first start-up AIDSfreeAFRICA supported. Support is given in form of expertise, technology and microloans. Diamond Pharmaceuticals is currently on hold until their board of directors decides otherwise.
GENEMARK PHARMACEUTICAL PRODUCTION
Dr. Gisele Etame is the majority shareholder and in charge of Genemark. This factory produces children’s syrups to treat a cough, malaria and fever/colds. This company wants to expand syrup production to keep up with demand and thereafter add solid oral drug tablet production. CEO Dr. Etame is successfully expanding production and gaining market shares.
CAMEROON BAPTIST CONVENTION PHARMACEUTICAL PRODUCTION
We are fortunate to have intensified our collaboration with the Cameroonian Baptist Convention. They produce sterile IV fluids, eye drops and ointments for internal use. They recently added drinking water/ bottling capabilities. Thanks in part to Hoffmann-La Roche Technology Transfer Initiative specialist Luc Schnitzler’s visit, the main players in Cameroons pharmaceutical production came together.